India, July 2 -- Theratechnologies Inc. (THTX,TH.TO) has agreed to be taken private by CB Biotechnology, LLC, an affiliate of Future Pak, LLC, for US$3.01 per share in cash, plus one contingent value right or CVR per share. Each CVR entitles shareholders to potential additional cash payments of up to US$1.19, contingent on certain milestones. The total transaction value, assuming full CVR payout, amounts to US$254 million.
The cash portion of the consideration offered to the company's shareholders under the Transaction and the combined cash and CVR consideration represent substantial and compelling premiums of 126% and 216%, respectively, to the closing price on the Nasdaq Capital Market on April 10, 2025, the date prior to the announcemen...